An Alternative Mechanism of Subcellular Iron Uptake Deficiency in Cardiomyocytes
- 7 July 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 133 (2) , E19-E46
Abstract
Background: Systemic defects in intestinal iron absorption, circulation, and retention cause iron deficiency in 50% of patients with heart failure. Defective subcellular iron uptake mechanisms that are independent of systemic absorption are incompletely understood. The main intracellular route for iron uptake in cardiomyocytes is clathrin-mediated endocytosis. Methods: We investigated subcellular iron uptake mechanisms in patient-derived and CRISPR/Cas–edited induced pluripotent stem cell–derived cardiomyocytes as well as patient-derived heart tissue. We used an integrated platform of DIA-MA (mass spectrometry data-independent acquisition)–based proteomics and signaling pathway interrogation. We employed a genetic induced pluripotent stem cell model of 2 inherited mutations ( TnT [ troponin T ]-R141W and TPM1 [ tropomyosin 1 ]-L185F) that lead to dilated cardiomyopathy (DCM), a frequent cause of heart failure, to study the underlying molecular dysfunctions of DCM mutations. Results: We identified a druggable molecular pathomechanism of impaired subcellular iron deficiency that is independent of systemic iron metabolism. Clathrin-mediated endocytosis defects as well as impaired endosome distribution and cargo transfer were identified as a basis for subcellular iron deficiency in DCM-induced pluripotent stem cell–derived cardiomyocytes. The clathrin-mediated endocytosis defects were also confirmed in the hearts of patients with DCM with end-stage heart failure. Correction of the TPM1-L185F mutation in DCM patient–derived induced pluripotent stem cells, treatment with a peptide, Rho activator II, or iron supplementation rescued the molecular disease pathway and recovered contractility. Phenocopying the effects of the TPM1-L185F mutation into WT induced pluripotent stem cell–derived cardiomyocytes could be ameliorated by iron supplementation. Conclusions: Our findings suggest that impaired endocytosis and cargo transport resulting in subcellular iron deficiency could be a relevant pathomechanism for patients with DCM carrying inherited mutations. Insight into this molecular mechanism may contribute to the development of treatment strategies and risk management in heart failure.Keywords
This publication has 111 references indexed in Scilit:
- Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signalingProceedings of the National Academy of Sciences, 2012
- The intracellular trafficking pathway of transferrinBiochimica et Biophysica Acta (BBA) - General Subjects, 2012
- Truncations of Titin Causing Dilated CardiomyopathyNew England Journal of Medicine, 2012
- Phosphatidylinositol-(4,5)-bisphosphate regulates clathrin-coated pit initiation, stabilization, and sizeMolecular Biology of the Cell, 2011
- Chemically defined conditions for human iPSC derivation and cultureNature Methods, 2011
- WASH and WAVE actin regulators of the Wiskott–Aldrich syndrome protein (WASP) family are controlled by analogous structurally related complexesProceedings of the National Academy of Sciences, 2010
- Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosolProceedings of the National Academy of Sciences, 2010
- Familial Dilated Cardiomyopathy Caused by an Alpha-Tropomyosin MutationJACC, 2010
- Role of lipids and actin in the formation of clathrin-coated pitsExperimental Cell Research, 2006
- Interactions of WASp, myosin-I, and verprolin with Arp2/3 complex during actin patch assembly in fission yeastJournal of Cell Biology, 2005